Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Alvotech - Ordinary Shares (NQ:ALVO)

4.820 -0.180 (-3.60%)

Streaming Delayed Price Updated: 10:21 AM EST, Dec 18, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	137,936
Open	5.030
Bid (Size)	4.820 (900)
Ask (Size)	4.840 (400)
Prev. Close	5.000
Today's Range	4.800 - 5.050
52wk Range	4.320 - 13.70
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

December 16, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Continues Investigations into Beyond Meat and Alvotech on Behalf of Stockholders and Encourages Investors to Contact the Firm

December 15, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Performance

YTD	-63.4%	-63.4%
1 Month	-6.2%	-6.2%
3 Month	-39.2%	-39.2%
6 Month	-46.5%	-46.5%
1 Year	-60.2%	-60.2%

More News

ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

December 12, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Earnings Scheduled For November 12, 2025 ↗

November 12, 2025

Via Benzinga

ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

December 09, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

December 06, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation – ALVO

December 04, 2025

From The Rosen Law Firm, P.A.

Via Business Wire

Alvotech’s Drug Approved In Europe As Biosimilar For Bone Disease Drug ↗

November 24, 2025

Via Stocktwits

Alvotech Announces Approval of AVT03, a Biosimilar to Prolia® and Xgeva® (denosumab) in the European Economic Area

November 24, 2025

From Alvotech

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Continues Investigations into Regencell, Beyond Meat, Alvotech, and Camping World on Behalf of Stockholders and Encourages Investors to Contact the Firm

November 22, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz®, a First-in-Market Biosimilar to Simponi® (golimumab)

November 20, 2025

From Alvotech

Via GlobeNewswire

ALVO Investigation: Investors Encouraged to Contact Kirby McInerney LLP

November 19, 2025

From Kirby McInerney LLP

Via Business Wire

Ardent Health, KinderCare Learning, Ibotta And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

November 13, 2025

Via Benzinga

Bragar Eagel & Squire, P.C. Is Investigating Regencell, Beyond Meat, Alvotech, and Camping World and Encourages Investors to Contact the Firm

November 12, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update

November 12, 2025

From Alvotech

Via GlobeNewswire

Uncovering Potential: Alvotech's Earnings Preview ↗

November 11, 2025

Via Benzinga

UK High Court Rules in Favor of Alvotech Paving Way for Manufacture and Market Entry of AVT06, biosimilar to Eylea® (aflibercept)

November 10, 2025

From Alvotech

Via GlobeNewswire

ALVOTECH ALERT: Bragar Eagel & Squire, P.C. is Investigating Alvotech on Behalf of Alvotech Stockholders and Encourages Investors to Contact the Firm

November 07, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA

November 06, 2025

From Alvotech

Via GlobeNewswire

ALVOTECH ALERT: Bragar Eagel & Squire, P.C. is Investigating Alvotech on Behalf of Alvotech Stockholders and Encourages Investors to Contact the Firm

November 05, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Alvotech INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (ALVO)

November 04, 2025

From Kirby McInerney LLP

Via GlobeNewswire

Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update

November 04, 2025

From Alvotech

Via GlobeNewswire

This Kimberly-Clark Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗

November 04, 2025

Via Benzinga

Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November ↗

November 04, 2025

Via Benzinga

Which stocks are moving on Monday? ↗

November 03, 2025

Via Chartmill

Frequently Asked Questions

Is Alvotech - Ordinary Shares publicly traded?

Yes, Alvotech - Ordinary Shares is publicly traded.

What exchange does Alvotech - Ordinary Shares trade on?

Alvotech - Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Alvotech - Ordinary Shares?

The ticker symbol for Alvotech - Ordinary Shares is ALVO on the Nasdaq Stock Market

What is the current price of Alvotech - Ordinary Shares?

The current price of Alvotech - Ordinary Shares is 4.820

When was Alvotech - Ordinary Shares last traded?

The last trade of Alvotech - Ordinary Shares was at 12/18/25 10:21 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.